Code of Conduct Disclosure
EyePoint, Inc. (the “Corporation”) periodically updates the EyePoint, Inc. Code of Conduct (the “Code”) applicable to all employees, including our principal executive officer, principal financial officer and principal accounting officer under U.S. Securities and Exchange Commission rules.
On February 25, 2026, changes were made to the Code, including updates or clarifications regarding (i) the new Company name “EyePoint, Inc.” from “EyePoint Pharmaceuticals, Inc.”, (ii) the creation and installation of the Company’s new Compliance Committee and Chief Compliance Officer Role, and (iii) a new section outlining healthcare compliance as we plan to re-enter the commercial space.
The above summary of the February 25, 2026 updates to the Code is qualified in its entirety by reference to the full text of the Code.